Vincerx Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vincerx Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q3 2024.
  • Vincerx Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.43M, a 41.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.43M -$1.02M -41.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.69M -$994K -37% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.95M -$973K -33.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.2M -$863K -28.2% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.45M -$844K -25.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.69M -$827K -23.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $2.92M -$810K -21.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.06M -$885K -22.4% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $3.29M -$878K -21.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.51M -$703K -16.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.73M +$361K +10.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.95M Dec 31, 2021 10-K 2023-03-28
Q3 2021 $4.17M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $4.22M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.37M Mar 31, 2021 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.